ZBH (STOCKS)
Zimmer Biomet Holdings, Inc.
$99.570000
+1.680000 (+1.72%)
Prev close: $97.890000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Ivan Tornos
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $19,169.96M
- Employees
- 17,000
- P/E (TTM)
- 23.82
- P/B (TTM)
- 1.48
- Dividend Yield
- 98.07%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
8
Buy
22
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$2.07 | $2.03 | +0.0406 | +2.00% |
|
Mar 2026 (Q1)
|
$2.09 | $1.88 | +0.2070 | +10.99% |
|
Dec 2025 (Q4)
|
$2.42 | $2.42 | +0.0001 | +0.00% |
|
Sep 2025 (Q3)
|
$1.90 | $1.89 | +0.0138 | +0.73% |
Financial Statements
| Revenues | $8.51B |
| Benefits Costs and Expenses | $7.58B |
| Cost Of Revenue | $2.56B |
| Costs And Expenses | $7.30B |
| Gross Profit | $5.95B |
| Operating Expenses | $4.74B |
| Selling, General, and Administrative Expenses | $3.43B |
| Depreciation and Amortization | $1.11B |
| Other Operating Expenses | $199.00M |
| Operating Income/Loss | $1.21B |
| Income/Loss From Continuing Operations After Tax | $807.00M |
| Income/Loss From Continuing Operations Before Tax | $933.60M |
| Income Tax Expense/Benefit | $126.60M |
| Interest Income/Expense After Provision For Losses | -$289.00M |
| Interest Income/Expense Operating, Net | -$289.00M |
| Net Income/Loss | $807.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $300.00K |
| Net Income/Loss Attributable To Parent | $806.70M |
| Net Income/Loss Available To Common Stockholders, Basic | $806.70M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | $4.13 |
| Diluted Earnings Per Share | $4.12 |
| Basic Average Shares | 585,000,000 |
| Diluted Average Shares | 587,100,000 |
| Assets | $22.80B |
| Current Assets | $5.10B |
| Inventory | $2.27B |
| Other Current Assets | $2.83B |
| Noncurrent Assets | $17.70B |
| Fixed Assets | $2.24B |
| Intangible Assets | $4.46B |
| Other Non-current Assets | $11.00B |
| Liabilities | $10.17B |
| Current Liabilities | $3.01B |
| Accounts Payable | $352.40M |
| Wages | $334.30M |
| Other Current Liabilities | $2.33B |
| Noncurrent Liabilities | $7.15B |
| Equity | $12.63B |
| Equity Attributable To Noncontrolling Interest | $8.70M |
| Equity Attributable To Parent | $12.62B |
| Liabilities And Equity | $22.80B |
| Net Cash Flow From Operating Activities | $1.74B |
| Net Cash Flow From Operating Activities, Continuing | $1.74B |
| Net Cash Flow From Investing Activities | -$835.10M |
| Net Cash Flow From Investing Activities, Continuing | -$835.10M |
| Net Cash Flow From Financing Activities | -$1.05B |
| Net Cash Flow From Financing Activities, Continuing | -$1.05B |
| Net Cash Flow | -$145.30M |
| Net Cash Flow, Continuing | -$145.30M |
| Comprehensive Income/Loss | $927.30M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $927.30M |
| Other Comprehensive Income/Loss | $120.60M |
| Other Comprehensive Income/Loss Attributable To Parent | $120.60M |